Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke (CONVINCE)
CONVINCE - (COlchicine for preventioN of Vascular Inflammation in Non- CardioEmbolic Stroke) - a Randomised Clinical Trial of Low-dose Colchicine for Secondary Prevention After Stroke
Sponsor: Health Research Board, Ireland
A PHASE3 clinical study on Ischemic Attack, Transient and Stroke, this trial is completed. The trial is conducted by Health Research Board, Ireland and has accumulated 12 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Jun 2025 — Sep 2025 [monthly]
Completed PHASE3
-
Apr 2025 — Jun 2025 [monthly]
Completed PHASE3
-
Sep 2024 — Apr 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
▶ Show 7 earlier versions
-
Apr 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
Status: Unknown Status → Active Not Recruiting
-
Nov 2022 — Apr 2023 [monthly]
Unknown Status PHASE3
-
Nov 2021 — Nov 2022 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Jan 2021 — Nov 2021 [monthly]
Recruiting PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Recruiting PHASE3
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Oct 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Health Research Board, Ireland
- Irish Heart Foundation
- National University of Ireland, Galway, Ireland
- Universitaire Ziekenhuizen KU Leuven
- Universitat de Lleida
- University College Dublin
- University of Edinburgh
- University of Limerick
For direct contact, visit the study record on ClinicalTrials.gov .